The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study
Objective: Neoadjuvant chemotherapy (NAC) is currently used in both early stage and locally advanced breast cancers. The survival benefits of standard vs. non-standard NAC cycles are still unclear. This study aimed to investigate the relationship between NAC cycles and survival based on real world d...
Main Authors: | Litong Yao, Zhiyuan Pang, Mozhi Wang, Mengshen Wang, Xiangyu Sun, Mingke Cui, Yanfu Zheng, Xinyan Li, Haoran Dong, Qiang Zhang, Yingying Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2022-05-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | https://www.cancerbiomed.org/content/19/5/755 |
Similar Items
-
An Immune Model to Predict Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Based on Support Vector Machine
by: Mozhi Wang, et al.
Published: (2021-04-01) -
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01) -
Transcriptome Meta-Analysis of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy
by: Wei Zhang, et al.
Published: (2023-04-01) -
Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: Alimoghadam K, et al.
Published: (2004-07-01) -
Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: K Alimoghadam, et al.
Published: (2004-03-01)